https://scholars.lib.ntu.edu.tw/handle/123456789/516779| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | FANG-JU LIN | en_US |
| dc.contributor.author | Shyu, Kou-Gi | en_US |
| dc.contributor.author | Hsieh, I-Chang | en_US |
| dc.contributor.author | Huey-Herng Sheu, Wayne | en_US |
| dc.contributor.author | Tu, Shih-Te | en_US |
| dc.contributor.author | Yeh, Shoou-Jeng | en_US |
| dc.contributor.author | Chen, Chin-I | en_US |
| dc.contributor.author | Lu, Kuo-Cheng | en_US |
| dc.contributor.author | Wu, Chia-Chao | en_US |
| dc.contributor.author | Shau, Wen-Yi | en_US |
| dc.contributor.author | Inocencio, Timothy J | en_US |
| dc.contributor.author | Wen, Yao-Chun | en_US |
| dc.contributor.author | Yeh, Hung-I | en_US |
| dc.date.accessioned | 2020-10-12T10:15:04Z | - |
| dc.date.available | 2020-10-12T10:15:04Z | - |
| dc.date.issued | 2020-05 | - |
| dc.identifier.issn | 0929-6646 | - |
| dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/516779 | - |
| dc.description.abstract | The recommended target low-density lipoprotein cholesterol (LDL-C) level for coronary artery disease (CAD) patients has been lowered from 100 to 70 mg/dL in several clinical guidelines for secondary prevention. We aimed to assess whether initiating statin treatment in CAD patients with baseline LDL-C 70-100 mg/dL in Taiwan could be cost-effective. | en_US |
| dc.language.iso | animation | en_US |
| dc.publisher | ELSEVIER TAIWAN | en_US |
| dc.relation.ispartof | Journal of the Formosan Medical Association = Taiwan yi zhi | en_US |
| dc.subject | Coronary artery disease; Cost-effectiveness analysis; Low-density lipoprotein cholesterol; Secondary prevention; Statin | en_US |
| dc.subject | Coronary artery disease; Cost-effectiveness analysis; Low-density lipoprotein cholesterol; Secondary prevention; Statin | - |
| dc.subject.other | atorvastatin; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; pitavastatin; rosuvastatin; simvastatin; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; Article; cardiac patient; cerebrovascular accident; cohort analysis; coronary artery disease; cost effectiveness analysis; drug cost; drug use; gross national product; health care cost; health status; heart infarction; human; incidence; major clinical study; Markov chain; mortality rate; probability; quality adjusted life year; recurrent disease; secondary prevention; sensitivity analysis; Taiwan; coronary artery disease; cost benefit analysis; economics; epidemiology; secondary prevention; Cholesterol, LDL; Coronary Artery Disease; Cost-Benefit Analysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Quality-Adjusted Life Years; Secondary Prevention; Taiwan | - |
| dc.subject.other | [SDGs]SDG3 | - |
| dc.title | Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan | en_US |
| dc.type | journal article | en_US |
| dc.identifier.doi | 10.1016/j.jfma.2020.01.010 | - |
| dc.identifier.pmid | 32081563 | - |
| dc.identifier.isi | WOS:000544560600003 | - |
| dc.relation.pages | 907 | en_US |
| dc.relation.journalvolume | 119 | en_US |
| dc.relation.journalissue | 5 | en_US |
| dc.relation.pageend | 916 | en_US |
| item.openairetype | journal article | - |
| item.languageiso639-1 | animation | - |
| item.fulltext | no fulltext | - |
| item.grantfulltext | none | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
| item.cerifentitytype | Publications | - |
| Appears in Collections: | 臨床藥學研究所 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.